Astellas Pharma Inc. (ALPMY)
OTC: ALPMY
· Real-Time Price · USD
11.33
0.15 (1.34%)
At close: Aug 15, 2025, 3:58 PM
11.30
-0.26%
After-hours: Aug 15, 2025, 03:58 PM EDT
Astellas Pharma Cash Flow Statement
Financials in JPY. Fiscal
year is
April - March.
Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 74.9B | -97.66B | 35.91B | 37.6B | -33.28B | 14.51B | -1.46B | 33.13B | -46.13B | 48.41B | 71.62B | 24.81B | -8.41B | 60.88B | 40.92B | 30.69B | -12.33B | 60.08B | 22.43B | 50.41B |
Depreciation & Amortization | 47.68B | 51.16B | 50.02B | 50.27B | 48.64B | 46.98B | 38.97B | 23.24B | 23.02B | 23B | 22.85B | 36.87B | 21.08B | 21.52B | 18.94B | 18.14B | -18.56B | 18.15B | 17.94B | 18B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | n/a | 14.47B | 23.08B | 18.28B | 14.55B | 20.97B | -18.99B | 64.46B | 27.84B | -13.77B | 19.67B | -3.96B | -29.45B | 21.82B | -5.05B | 5.25B | 42.46B | 10.23B | -10.56B |
Other Non-Cash Items | 961M | 134.68B | -1.24B | -49.27B | 130.14B | 3.2B | 4.42B | 17.78B | 49.29B | -7.45B | 62.81B | 101.92B | 71.66B | 45.2B | 19.1B | 82.53B | 53.66B | 567M | 11.41B | -19.83B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -22.46B | -72.16B | -19.87B | -26B | 22.31B | -11.62B | -1.85B | -60.54B | 91.88B | 9.43B | -16.8B | -10.54B | 1.31B | -22.14B | 40.1B | -29.95B | 28.87B | 31.39B | 41.58B | -26.98B |
Operating Cash Flow | 101.08B | 16.03B | 64.81B | 12.6B | 74.55B | 53.08B | 40.08B | 13.61B | 118.07B | 73.38B | 91.76B | 49.12B | 48.75B | 69.73B | 99.46B | 40.22B | 82.18B | 110.18B | 93.36B | 21.6B |
Capital Expenditures | -9.7B | 2.29B | -15.6B | -14B | -19.92B | -15.27B | -30.94B | -16.36B | -28.12B | -20.73B | -21.43B | -18.26B | -17.27B | -11.3B | -27.96B | -19.91B | -18.58B | -8.96B | -6.37B | -7.59B |
Cash Acquisitions | n/a | n/a | n/a | n/a | -190M | -24.73B | -760.05B | n/a | n/a | n/a | n/a | n/a | 25M | 139M | 69M | -462M | 251M | -13.2B | -40M | -1.67B |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.62B | 64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 6.73B | -33.02B | -782M | -25.35B | -8.25B | -1.97B | 16.76B | 2.65B | -9.7B | -7.51B | 5.18B | -1.17B | 2.25B | 19.06B | -6.92B | -846M | 1.09B | -7.29B | -3.55B | -19.08B |
Investing Cash Flow | -2.96B | -30.72B | -16.38B | -39.35B | -24.73B | -41.98B | -774.23B | -13.72B | -25.19B | -28.18B | -16.25B | -19.43B | -14.99B | 7.9B | -34.82B | -21.22B | -14.64B | -29.45B | -9.96B | -28.33B |
Debt Repayment | -23.55B | -15.57B | -16.49B | n/a | 43.12B | -17.23B | 511.35B | 234B | -50B | 50B | -30B | 15B | -20B | n/a | -40B | n/a | -45B | -19B | -32B | -30B |
Common Stock Repurchased | -1M | -1M | -1M | -6.96B | -1M | -2M | -1M | -10.73B | -50B | -2M | n/a | -10.55B | -50B | -1M | -2M | -713M | -8.28B | -1M | -1M | -880M |
Dividend Paid | n/a | -66.23B | n/a | -62.76B | n/a | -62.75B | n/a | -53.9B | n/a | -54.68B | n/a | -45.68B | n/a | -46.32B | n/a | -38.91B | n/a | -39.01B | n/a | -37.15B |
Other Financial Acitivies | -67.26B | -22.49B | -37.85B | 50.84B | -12.19B | -7.04B | -6.23B | -4.33B | -4.5B | -5.01B | -4.83B | -5.37B | -5.03B | -5B | -5.2B | -5.1B | -4.86B | -3.59B | -4.76B | -4.95B |
Financial Cash Flow | -90.81B | -104.3B | -54.34B | -11.92B | 30.93B | -87.03B | 505.12B | 165.04B | -104.5B | -9.69B | -34.83B | -46.6B | -75.03B | -51.33B | -45.21B | -44.73B | -58.14B | -61.6B | -36.76B | -72.98B |
Net Cash Flow | 8.51B | 179.87B | -302.93B | 302.93B | 81.71B | -80.02B | -227.49B | 184.65B | -4.98B | 20.74B | 48.06B | -2.97B | -34.23B | 31.92B | 16.38B | -24.21B | 19.61B | 19.78B | 46.8B | -78.46B |
Free Cash Flow | 91.38B | 18.32B | 49.21B | -1.4B | 54.63B | 37.81B | 9.14B | -2.75B | 89.95B | 52.65B | 70.33B | 30.86B | 31.48B | 58.43B | 71.5B | 20.31B | 63.6B | 101.22B | 86.99B | 14.01B |